153 related articles for article (PubMed ID: 22827249)
21. The p53 pathway: targets for the development of novel cancer therapeutics.
Wang S; El-Deiry WS
Cancer Treat Res; 2004; 119():175-87. PubMed ID: 15164878
[No Abstract] [Full Text] [Related]
22. Introduction to ion channels.
Di Resta C; Becchetti A
Adv Exp Med Biol; 2010; 674():9-21. PubMed ID: 20549936
[TBL] [Abstract][Full Text] [Related]
23. Biologically active, synthetic ion transporters.
Gokel GW; Carasel IA
Chem Soc Rev; 2007 Feb; 36(2):378-89. PubMed ID: 17264938
[TBL] [Abstract][Full Text] [Related]
24. Editorial to the Special Issue "Electrophysiology".
Wu SN; Huang CW
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803919
[TBL] [Abstract][Full Text] [Related]
25. Antiarrhythmics--from cell to clinic: past, present, and future.
Hancox JC; Patel KC; Jones JV
Heart; 2000 Jul; 84(1):14-24. PubMed ID: 10862579
[No Abstract] [Full Text] [Related]
26. Potassium channels are a new target field in anticancer drug design.
Villalonga N; Ferreres JC; Argilés JM; Condom E; Felipe A
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):212-23. PubMed ID: 18221064
[TBL] [Abstract][Full Text] [Related]
27. Editorial: Azoles in Anticancer Research: Rational Approaches, Design Strategies, Recent Insights and Future Perspectives.
Gupta GK
Anticancer Agents Med Chem; 2018; 18(1):4-5. PubMed ID: 29561251
[No Abstract] [Full Text] [Related]
28. Drug resistance modulation in the laboratory and the clinic.
Dalton WS
Semin Oncol; 1993 Feb; 20(1):64-9. PubMed ID: 8475411
[No Abstract] [Full Text] [Related]
29. Introduction: Applying Chemical Biology to Ion Channels.
Pless SA; Ahern CA
Adv Exp Med Biol; 2015; 869():1-4. PubMed ID: 26381937
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular ion channels as a molecular target of flavonoids.
Scholz EP; Zitron E; Katus HA; Karle CA
Cardiovasc Ther; 2010 Aug; 28(4):e46-52. PubMed ID: 20633021
[TBL] [Abstract][Full Text] [Related]
31. Ion channels/transporters as epigenetic regulators? -a microRNA perspective.
Jiang X; Zhang JT; Chan HC
Sci China Life Sci; 2012 Sep; 55(9):753-60. PubMed ID: 23015123
[TBL] [Abstract][Full Text] [Related]
32. A comment on ion channels as pharmacological targets in oncology.
Becchetti A; Arcangeli A
J Gen Physiol; 2008 Aug; 132(2):313-4. PubMed ID: 18663136
[No Abstract] [Full Text] [Related]
33. Editorial: Drug Design and Discovery Targeting Ion Channels.
Li X
Curr Top Med Chem; 2016; 16(16):1763. PubMed ID: 27165197
[No Abstract] [Full Text] [Related]
34. Cardiac ion channels.
Katz AM
N Engl J Med; 1993 Apr; 328(17):1244-51. PubMed ID: 7681934
[No Abstract] [Full Text] [Related]
35. Properties and regulation of ion channels in MDCK cells.
Lang F; Paulmichl M
Kidney Int; 1995 Oct; 48(4):1200-5. PubMed ID: 8569081
[TBL] [Abstract][Full Text] [Related]
36. Ion channels as a target for drug design.
Tai KK
Curr Pharm Des; 2007; 13(31):3168. PubMed ID: 18045165
[No Abstract] [Full Text] [Related]
37. Editorial: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer Therapy.
Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):100. PubMed ID: 26791134
[No Abstract] [Full Text] [Related]
38. CXCR4 receptor as a promising target for oncolytic drugs.
Lavrovsky Y; Ivanenkov YA; Balakin KV; Medvedeva DA; Ivachtchenko AV
Mini Rev Med Chem; 2008 Oct; 8(11):1075-87. PubMed ID: 18855724
[TBL] [Abstract][Full Text] [Related]
39. Ion channels: too complex for rational drug design?
Goldstein SA; Colatsky TJ
Neuron; 1996 May; 16(5):913-9. PubMed ID: 8630249
[No Abstract] [Full Text] [Related]
40. Bioelectrical regulation of cell cycle and the planarian model system.
Barghouth PG; Thiruvalluvan M; Oviedo NJ
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2629-37. PubMed ID: 25749155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
